Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA
Open Access
- 1 November 2020
- Vol. 75 (11), 2867-2878
- https://doi.org/10.1111/all.14408
Abstract
Background Chronic rhinosinusitis (CRS) is a chronic inflammatory disease associated with a substantial personal and socioeconomic burden. Monitoring of patient-reported outcomes by mobile technology offers the possibility to better understand real-life burden of CRS. Methods This study reports on the cross-sectional evaluation of data of 626 users of mySinusitisCoach (mSC), a mobile application for CRS patients. Patient characteristics of mSC users were analysed as well as the level of disease control based on VAS global rhinosinusitis symptom score and adapted EPOS criteria. Results The mSC cohort represents a heterogeneous group of CRS patients with a diverse pattern of major symptoms. Approximately half of patients reported nasal polyps. 47.3% of all CRS patients were uncontrolled based on evaluation of VAS global rhinosinusitis symptom score compared to 40.9% based on adapted EPOS criteria. The impact of CRS on sleep quality and daily life activities was significantly higher in uncontrolled versus well-controlled patients. Half of patients had a history of FESS (functional endoscopic sinus surgery) and reported lower symptom severity compared to patients without a history of FESS, except for patients with a history of more than 3 procedures. Patients with a history of FESS reported higher VAS levels for impaired smell. Conclusion Real-life data confirm the high disease burden in uncontrolled CRS patients, clearly impacting quality of life. Sinus surgery improves patient-reported outcomes, but not in patients with a history of more than 3 procedures. Mobile technology opens a new era of real-life monitoring, supporting the evolution of care towards precision medicine.This publication has 38 references indexed in Scilit:
- Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & ImmunologyJournal of Allergy and Clinical Immunology, 2016
- Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkersJournal of Allergy and Clinical Immunology, 2016
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal PolyposisJAMA, 2016
- ICON: chronic rhinosinusitisWorld Allergy Organization Journal, 2014
- Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthmaJournal of Allergy and Clinical Immunology, 2012
- Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposisJournal of Allergy and Clinical Immunology, 2011
- Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in EuropeAllergy, 2011
- Association between Severity of Asthma and Degree of Chronic RhinosinusitisAmerican Journal of Rhinology and Allergy, 2011
- Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN studyAllergy, 2011
- Relationships between Severity of Chronic Rhinosinusitis and Nasal Polyposis, Asthma, and AtopyAmerican Journal of Rhinology and Allergy, 2009